Cox-2 nonsteroidal anti-inflammatory

The new concerns prompted the FDA in 2005 to require new warnings on all NSAIDs (except aspirin), stating the risk of stomach, heart, or skin problems. Ulcers and gastrointestinal bleeding linked to the use of NSAIDs are responsible for an estimated 15,000 to 20,000 deaths in the . each year, and more than 100,000 hospitalizations, according to the American College of Gastroenterology. In February 2007 the American Heart Association advised physicians that, except for aspirin, NSAIDs and especially COX-2 inhibitors should be used only as a last line of treatment for people with heart disease or heart disease risk factors.

Cox-2 nonsteroidal anti-inflammatory

cox-2 nonsteroidal anti-inflammatory

Media:

cox-2 nonsteroidal anti-inflammatorycox-2 nonsteroidal anti-inflammatorycox-2 nonsteroidal anti-inflammatorycox-2 nonsteroidal anti-inflammatorycox-2 nonsteroidal anti-inflammatory